UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2020 Earnings Conference Call August 10, 2020 8:30 AM ET Company Participants Kate Bechtold - Senior Director, IR Liz Barrett - President & CEO Mark Schoenberg - Chief Medical Officer Jeff Bova - SVP, Commercial Peter Pfreundschuh - CFO Conference Call Participants Boris Peaker - Cowen Leland Gershell - Oppenheimer Paul Choi - Goldman Sachs Matt Kaplan - Ladenburg Thalmann Operator Thank you for standing by and welcome to the UroGen Pharma Second Quarter 2020 Financial Re ...

UROGEN CORPORATE PRESENTATION JEFFERIES HEALTHCARE CONFERENCE June 2, 2020 2 FORWARD LOOKING STATEMENTS This investor presentation contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation: the potential market opportunity of Jelmyto in LG-UTUC; commercial plans for favorable market access and physician uptake following the Jelmyto launch; plans for the successful launch of Jelmyto; the timing for completion of commerci ...

UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2020 Earnings Conference Call May 7, 2020 8:30 AM ET Company Participants | --- | --- | |-------|-----------------------------------------------------| | | | | | Kate Bechtold - Senior Director, Investor Relations | | | Liz Barrett - President & Chief Executive Officer | | | Mark Schoenberg - Chief Medical Officer | | | Jeff Bova - Senior Vice President, Commercial | | | Peter Pfreundschuh - Chief Financial Officer | | | Conference Call Participants | | | Derek Archila - ...

UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2019 Earnings Conference Call March 2, 2020 8:30 AM ET Company Participants Kate Bechtold - Senior Director, Investor Relations Liz Barrett - President and Chief Executive Officer Mark Schoenberg - Chief Medical Officer Peter Pfreundschuh - Chief Financial Officer Jeff Bova - Senior Vice President, Commercial Conference Call Participants Derek Archila - Stifel Nicolaus Chris Howerton - Jefferies Paul Choi - Goldman Sachs Ram Selvaraju - H.C. Wainwright & Co. Matthew Kapla ...

UroGen Pharma Ltd. (NASDAQ:URGN) Q3 2019 Earnings Conference Call November 12, 2019 8:30 AM ET Company Participants Catherine Bechtold - Senior Director of IR Elizabeth Barrett - President and CEO Mark Schoenberg - Chief Medical Officer Peter Pfreundschuh - CFO Stephen Mullennix - COO Jeff Bova - SVP, Commercial Conference Call Participants Turner Kufe - JPMorgan Ram Selvaraju - H. C. Wainwright Boris Peaker - Cowen Leland Gershell - Oppenheimer Operator Good morning, ladies and gentlemen, thank you for sta ...

UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2019 Earnings Conference Call August 12, 2019 8:30 AM ET Company Participants Catherine Bechtold - Director of Corporate Communications & IR Elizabeth Barrett - President, CEO Mark Schoenberg - Chief Medical Officer Peter Pfreundschuh - CFO & Secretary Stephen Mullennix - Chief Operating Officer Jeff Bova - Senior Vice President of Commercial Conference Call Participants Paul Choi - Goldman Sachs Boris Peaker - Cowen Ram Selvaraju - H.C. Wainwright Chris Howerton - Jeffer ...

| --- | --- | |-----------------------------------------|-------| | | | | | | | | | | | | | Transforming Therapies in Uro-Oncology | | | June 2019 Corporate Presentation | | Forward-Looking Statements 2 This presentation and the accompanying oral presentation by UroGen Pharma Ltd. ("UroGen") contains forward-looking statements. All statements contained herein other than statements of historical fact constitute forward-looking statements, including statements regarding UroGen's anticipated results of operati ...

UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2019 Earnings Conference Call May 9, 2019 8:30 AM ET Company Participants Kate Bechtold - IR Liz Barrett - President and CEO Mark Schoenberg - CMO Peter Pfreundschuh - CFO Conference Call Participants Derek Archila - Stifel Ram Selvaraju - H.C. Wainwright Boris Peaker - Cowen Matt Kaplan - Ladenburg Thalmann Chris Howerton - Jefferies Operator Good morning, ladies and gentlemen. Thank you for standing by and welcome to UroGen Pharma's First Quarter 2019 Financial Results ...

| --- | --- | |-------------------------------------------------------------------------|-------| | | | | | | | | | | | | | | | | Transforming Local Therapies in Uro-Oncology | | | March 12, 2019 Cowen and Company 39 th Annual Health Care Conference | | Forward-Looking Statements 2 This presentation and the accompanying oral presentation by UroGen Pharma Ltd. ("UroGen") contains forward-looking statements. All statements contained herein other than statements of historical fact constitute forward-looking st ...

UroGen Pharma (NASDAQ:URGN) Q4 2018 Earnings Conference Call February 28, 2019 8:30 AM ET Company Participants Kate Bechtold - Director, Corporate Communications and Investor Relations Liz Barrett - President and Chief Executive Officer Mark Schoenberg - Chief Medical Officer Peter Pfreundschuh - Chief Financial Officer Conference Call Participants Ram Selvaraju - H. C. Wainwright Boris Peaker - Cowen Leland Gershell - Oppenheimer Chris Howerton - Jefferies Operator Good morning, ladies and gentlemen. Thank ...